drugset / Trial / NCT07588646
Study To Investigate The Potential DDI Between HEC585 And Pirfenidone/Nintedanib In Healthy Subjects
Non-randomizedSequentialOpen-labelTreatment
Summary
A single-center, open-label study designed to assess the drug-drug interaction of HEC585 and pirfenidone in healthy male and female subjects. A single-center, open-label study designed to assess the drug-drug interaction of HEC585 and nintedanib in healthy male subjects.
Timeline
- Start
- 2021-06-29
- Primary completion
- 2021-11-30
- Completion
- 2021-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC585 | Small molecule | — | — |
| Subject | Nintedanib | Small molecule | — | — |
| Subject | Pirfenidone | Small molecule | — | — |